Concepedia

Thomas S. Hilzinger

TS

4

Publications

58

Citations

4

H-Index

2017

Active since

Affiliations

PricewaterhouseCoopers (United States)(Current)

UCB Pharma (Belgium)

AbbVie (United States)

Thomas S. Hilzinger is an author at PricewaterhouseCoopers (United States) specializing in medicine, transcriptional regulation, and systems biology.

Top concepts

Publications per year

2017–2019

4

Publications

4

Two-Element Transcriptional Regulation in the Canonical Wnt Pathway

Kibeom Kim, Jaehyoung Cho, Thomas S. Hilzinger et al. · Current Biology · 2017 · 18 citations · Full text

, , +7

Single molecule glycosylase studies with engineered 8-oxoguanine DNA damage sites show functional defects of a MUTYH polyposis variant

Shane R. Nelson, Scott D. Kathe, Thomas S. Hilzinger et al. · Nucleic Acids Research · 2019 · 15 citations · Full text

, , +20

Pooling Different Safety Data Sources: Impact of Combining Solicited and Spontaneous Reports on Signal Detection In Pharmacovigilance

Jeremy D. Jokinen, Rosalind Walley, Michael W. Colopy et al. · Drug Safety · 2019 · 15 citations · Full text

Industry Assessment of the Contribution of Patient Support Programs, Market Research Programs, and Social Media to Patient Safety

Jeremy D. Jokinen, Dominique Bertin, Bruce A. Donzanti et al. · Therapeutic Innovation & Regulatory Science · 2019 · 10 citations · Full text

Rows per page

1–4 of 4